Related Experiment Video
Updated: Aug 8, 2026

05:37
Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis
Published on: May 9, 2012
Bilateral internal mammary artery grafting
Antonio Maria Calafiore1, Michele Di Mauro
1Universty of CataniaVia Citelli, Division of Cardiac Surgery, 96100 Catania, Italy. calafiore@unich.it
Expert Review of Cardiovascular Therapy
|May 24, 2006
Summary
Bilateral internal mammary artery (BIMA) grafting improves survival and quality of life in myocardial revascularization patients, including diabetics. Techniques like skeletonization and optimal RIMA targeting mitigate risks, making BIMA a superior surgical option.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Thoracic Surgery
Background:
- The left internal mammary artery shows superiority over saphenous vein grafts for myocardial revascularization.
- Bilateral internal mammary artery (BIMA) grafting is considered for improved long-term outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of BIMA grafting in myocardial revascularization.
- To address the limitations and optimize the use of BIMA, particularly in diabetic patients.
Main Methods:
- Skeletonization of the internal mammary artery.
- Improved glucose control in diabetic patients.
- Utilizing Y or T configurations for double mammary artery grafts.
- Targeting the RIMA to specific coronary artery regions, such as the lateral wall.
Main Results:
- BIMA grafting demonstrates superiority over single internal mammary artery grafting in terms of survival and quality of life.
- Skeletonization and better glucose control significantly reduce deep sternal wound complications.
- RIMA grafting to the lateral wall and Y/T configurations improve graft utilization and efficiency.
- These benefits extend to diabetic patients, enhancing their survival and quality of life.
Conclusions:
- Bilateral internal mammary artery grafting is a superior surgical option for myocardial revascularization, offering improved long-term survival and quality of life.
- Addressing technical challenges and patient-specific factors, such as diabetes, optimizes BIMA's benefits.
- BIMA should be strongly considered for patients undergoing myocardial revascularization.
